AA

AAIPHARMA INC

  • CIK: 0001013243
  • EIN: 04-2687849
  • Business address: 2320 SCIENTIFIC PARK DRIVE, WILMINGTON, North Carolina, 28405

Information

  • Mailing address
    2320 SCIENTIFIC PARK DRIVE, WILMINGTON, Delaware, 28405
  • Phone
    9102547000
  • State location
    North Carolina
  • State of incorporation
    Delaware
  • Fiscal year end
    December 31
  • SIC
    8734 - (CF Office: Office of Trade & Services) SERVICES-TESTING LABORATORIES
  • Filings
    N/A

About AAIPHARMA INC

AAIPHARMA INC (CIK: 0001013243) is an American company incorporated in the state of North Carolina. Head office is located at 2320 SCIENTIFIC PARK DRIVE, WILMINGTON, North Carolina, 28405. Work in the industry 8734 - (CF Office: Office of Trade & Services) SERVICES-TESTING LABORATORIES. AAIPHARMA INC is a public company and trade via Over-The-Counter (OTC).

Old names:

  • APPLIED ANALYTICAL INDUSTRIES INC from 1996-25-Sep to 2000-01-Aug

Ownership

Owner Filings Transaction Date Type of Owner
Mangiardi Vito J 0001339044 Sep-06-2005 officer: Pres. N. American Operations
CZAJKOWSKI MATTHEW E 0001208291 Dec-01-2004 officer: Exec. VP and CFO
Reynders Ludo J 0001304891 Sep-27-2004 officer: Chief Executive Officer, CEO
GEORGE MICHAEL W 0001190102 Jul-26-2004 officer: Executive VP, Chief Admin. Off
Harrington John W 0001298633 Jul-19-2004 officer: Executive VP-Human Resources
Gutzeit Gina 0001291270 May-11-2004 officer: Interim, CFO
WRIGHT TIMOTHY R 0001288245 Apr-12-2004 officer: President, Pharmaceuticals Grp
RAYBURN GREGORY F 0001285021 Mar-23-2004 officer: Interim Chief Operating Office
LINDGREEN BOWIN M 0001275948 Jan-05-2004 officer: Sr. VP Corp. HR & Strat. Plans
FREDERICK D SANCILIO & BARBARA A SANCILIO INTANGIBLE TAX TR 0001274468 Dec-30-2003 10 percent owner
SANCILIO FREDERICK D 0001212269 Dec-24-2003 director, 10 percent owner, officer: Executive Chairman, CSO
WATERS JAMES L 0001024630 Nov-20-2003 director
LANDGRAF KURT M 0001179519 Nov-20-2003 director
MARTIN JAMES G 0001222832 Nov-20-2003 director
MORRISON RICHARD G 0001222906 Nov-20-2003 director
TABBINER PHILLIP S 0001222907 Nov-20-2003 director, officer: President and CEO
AVERY JOHN E 0001223007 Nov-20-2003 director
GINNA WILLIAM L JR 0001224038 Nov-20-2003 officer: EVP and CFO
HOGAN JOHN D 0001224040 Nov-20-2003 officer: Chief Acct. Off./Controller
HURLEY DAVID M 0001224041 Nov-20-2003 officer: President, aaiPharma LLC
RYAN JOHN MICHAEL 0001271154 Nov-20-2003 director
GOLDMAN SACHS & CO 0000769993 Oct-23-2003 10 percent owner
GOLDMAN SACHS GROUP INC/ 0000886982 Oct-23-2003 10 percent owner
STONE STREET FUND 1995 0000941168 Oct-23-2003 10 percent owner
BRIDGE STREET FUND 1995 LP 0000941186 Oct-23-2003 10 percent owner
GS CAPITAL PARTNERS II L P 0000945125 Oct-23-2003 10 percent owner
GLEBERMAN JOSEPH H 0001029609 Oct-23-2003 director
GOLDMAN SACHS & CO OHG 0001031766 Oct-23-2003 10 percent owner
GS CAPITAL PARTNERS II OFFSHORE LP 0001031770 Oct-23-2003 10 percent owner
GS CAPITAL PARTNERS II GERMANY CLP 0001035098 Oct-23-2003 10 percent owner
GS ADVISORS II LLC 0001232082 Oct-23-2003 10 percent owner
GS ADVISORS LLC 0001232084 Oct-23-2003 10 percent owner
STONE STREET 1995 LLC 0001232096 Oct-23-2003 10 percent owner
VAN LEAR GEORGE E 0001224036 Jun-04-2003 officer: Executive Vice President
BENTLEY GREGORY SMITH 0001224042 Jun-04-2003 officer: Executive VP & General Counsel
AGGARWAL VIJAY 0001224039 Jun-02-2003 officer: Executive Vice President
UNDERWOOD WILLIAM H 0001212268 May-02-2003 director, officer: Executive Vice President

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by AAIPHARMA INC

Filings Format Description Filed/Effective File/Film Number
15-12G Document

Notice of termination of registration of a class of securities under Section 12(g)

Acc-no: 0000950144-06-002073 (34 Act) Size: KB		 Mar-10-2006

000-21185

06678792
8-K Document

Current report filing

Acc-no: 0000950144-06-000215 (34 Act) Size: KB		 Jan-11-2006

000-21185

06525487
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0000950144-05-011529 (34 Act) Size: KB		 Nov-09-2005

000-21185

051190651
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0000950144-05-011526 (34 Act) Size: KB		 Nov-09-2005

000-21185

051190563
8-K/A Document

Amendment to Current report filing

Acc-no: 0000950144-05-011516 (34 Act) Size: KB		 Nov-09-2005

000-21185

051190466
8-K Document

Current report filing

Acc-no: 0000950144-05-011186 (34 Act) Size: KB		 Nov-07-2005

000-21185

051182035
3 Document

Initial statement of beneficial ownership of securities

Acc-no: 0001339044-05-000001 ( Act) Size: 0 KB		 Sep-16-2005

8-K Document

Current report filing

Acc-no: 0000950144-05-008789 (34 Act) Size: KB		 Aug-15-2005

000-21185

051027060
8-K Document

Current report filing

Acc-no: 0000950144-05-008433 (34 Act) Size: KB		 Aug-09-2005

000-21185

051008237
NT 10-Q Document

Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

Acc-no: 0000950144-05-008427 (34 Act) Size: KB		 Aug-09-2005

000-21185

051007917
8-K Document

Current report filing

Acc-no: 0000950144-05-007915 (34 Act) Size: KB		 Jul-29-2005

000-21185

05983883
8-K Document

Current report filing

Acc-no: 0000950144-05-007599 (34 Act) Size: KB		 Jul-22-2005

000-21185

05967563
8-K Document

Current report filing

Acc-no: 0000950144-05-006407 (34 Act) Size: KB		 Jun-13-2005

000-21185

05891428
4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001291271-05-000001 ( Act) Size: 0 KB		 May-23-2005

8-K Document

Current report filing

Acc-no: 0000950144-05-005433 (34 Act) Size: KB		 May-12-2005

000-21185

05824591
8-K Document

Current report filing

Acc-no: 0000950144-05-005059 (34 Act) Size: KB		 May-09-2005

000-21185

05809673
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0000950144-05-004945 (34 Act) Size: KB		 May-05-2005

000-21185

05804725
10-K Document

Annual report pursuant to section 13 and 15(d)

Acc-no: 0000950144-05-004448 (34 Act) Size: KB		 Apr-27-2005

000-21185

05777374
8-K Document

Current report filing

Acc-no: 0000950144-05-003898 (34 Act) Size: KB		 Apr-15-2005

000-21185

05752479
8-K Document

Current report filing

Acc-no: 0000950144-05-003472 (34 Act) Size: KB		 Apr-04-2005

000-21185

05727156

Recent 20 filings. View all AAIPHARMA INC filings

Reviews

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Frequently Asked Questions

Tags:

  • AAIPHARMA INC overview
  • AAIPHARMA INC job
  • AAIPHARMA INC stock
  • AAIPHARMA INC ownership
  • AAIPHARMA INC CEO
  • AAIPHARMA INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

UL Solutions Inc.
Update: Nov 14, 2023
Wavemaker Labs Asia Inc.
Update: Aug 25, 2022
VICAR OPERATING INC
Update: Aug 24, 2022
U S LABORATORIES INC
Update: Aug 24, 2022
THERMO TERRATECH INC
Update: Aug 23, 2022
RESPONSE BIOMEDICAL CORP
Update: Aug 20, 2022

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 4267 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 3344 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 4194 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 2245 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 3204 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 3366 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 2840 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 2777 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 3920 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by